Comments on: Genetic substudy shows fewer major cardiovascular events with ticagrelor (brilinta) regardless of relevant genetic variability in ACS patients

Comments on: Genetic substudy shows fewer major cardiovascular events with ticagrelor (brilinta) regardless of relevant genetic variability in ACS patients https://www.worldpharmatoday.com/research-insight/genetic-substudy-shows-fewer-major-cardiovascular-events-with-ticagrelor-brilinta-regardless-of-relevant-genetic-variability-in-acs-patients/ Magazine for the C-level Pharma Executives Sat, 28 Aug 2010 18:30:00 +0000 hourly 1 https://wordpress.org/?v=7.0